Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia

, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) chemotherapy and followed at periodic intervals to determine the primary and secondary objectives.

granulocyte colony stimulating factor
direct bilirubin
cladribine
cytarabine
ejection fraction
  • 60 views
  • 01 May, 2022
  • 1 location
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

leukemia difficult. So we propose a new treatment plan by using the therapy that rhTPO may promote the leukemia cells into the division cycle.We use the synergistic effect of G-CSF and rhTPO to promote

cancer
granulocyte colony stimulating factor
filgrastim
colony stimulating factor
decitabine
  • 0 views
  • 18 Feb, 2022
  • 1 location
A Phase II Study of Enhancing Anti-Tetanus Vaccine Response After Autologous Stem Cell Transplantation

transplantation of a mobilized graft product followed by an autologous lymphocyte infusion collected prior to G-CSF mobilization. All subjects will receive tetanus vaccines pre and post-transplant. The primary

granulocyte colony stimulating factor
monoclonal protein
melphalan
ejection fraction
lenalidomide
  • 3 views
  • 13 Oct, 2022
  • 1 location
GM-CSF With Post-Transplant Cyclophosphamide

recovery rates to G-CSF with a potential of lowering risk of infectious complications.

  • 0 views
  • 26 Apr, 2022
  • 1 location
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy (PEACH)

(TTRNA-xALT) and Autologous G-CSF mobilized Hematopoietic Stem Cells (HSCs)).

cancer
bone marrow procedure
granulocyte colony stimulating factor
filgrastim
colony stimulating factor
  • 0 views
  • 14 May, 2022
  • 2 locations
A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS

medication called granulocyte colony stimulating factor (G-CSF), and supplemental immunoglobulin (antibody). These therapies are expensive, nonspecific, have significant side effects and toxicities, and do

granulocyte colony stimulating factor
neutrophils
warts
HIV Infection
bone marrow transplant
  • 112 views
  • 10 Oct, 2022
  • 1 location
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

the disease. The investigators conducted a clinical study to evaluate the efficacy and safety of the AZA plus HAG(homoharringtonie, cytarabine, G-CSF), HIA(homoharringtonie, Idarubicin, cytarabine

granulocyte colony stimulating factor
cytarabine
idarubicin
azacitidine
filgrastim
  • 0 views
  • 07 Oct, 2022
  • 1 location
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

hyperhydration. G-CSF support from 4 to 13 days. Methotrexate 12 g / m2 at 28 and 35 days IV with leucovorin 60 mg / m2 in the first 5 days after each administration of methotrexate. The interval between cycles

renal function
methotrexate
g-csf
filgrastim
doxorubicin
  • 0 views
  • 10 Mar, 2022
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

cells with G-CSF and subsequent apheresis will take place. Then, patients will receive one additional induction cycle with belantamab mafodotin (8-week cycle) and two additional induction cycles with

granulocyte colony stimulating factor
filgrastim
dexamethasone
colony stimulating factor
melphalan
  • 0 views
  • 13 Dec, 2021
  • 19 locations
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

This study involves evaluating a combination of chemotherapy drugs known as "CLAG-GO" [cladribine, cytarabine, granulocyte-colony stimulating factor (G-CSF) and gemtuzumab ozogamicin (GO)] in

remission
chemotherapy drugs
gemtuzumab ozogamicin
g-csf
hematologic disorder
  • 8 views
  • 15 Mar, 2022
  • 1 location